Heart drug tested to help patients escape life support
NCT ID NCT04158674
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called levosimendan to see if it could help people with severe heart failure successfully come off a temporary heart-lung machine (ECLS). The trial planned to include 82 adults who were ready to try weaning off the machine. Half would get the drug and half a placebo. The study was stopped early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Dijon Bourgogne
Dijon, 21079, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Are heart failure patients taking their meds? a urine test at the ER aims to find out
- Can common heart drugs stay safe during a crisis? a trial investigates
- Heart failure fluid removal device trial halted early
- Massive new registry aims to unlock secrets of deadly heart shock
- Heart failure study aims to tailor treatments using biomarkers
- New device automates fluid removal in heart failure – could it be a game changer?